banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4

Oxford spinout RADiCAIT uses AI to make diagnostic imaging more affordable and accessible — catch it at TechCrunch Disrupt 2025

If you’ve ever had a PET scan, you know it’s an ordeal. The scans help doctors detect cancer and track its spread, but the process itself is a logistical nightmare for patients.  It starts with fasting for four to six hours before coming into the hospital — and good luck to you if you live … Read more

RealSense spins out of Intel to scale its stereoscopic imaging technology

After 14 years of developing inside of semiconductor giant Intel, RealSense is striking out on its own. RealSense sells cameras that use stereoscopic imaging, a process that combines two images of the same object from different angles to create depth, enhanced with infrared light. This technology helps machines like robots, drones, and autonomous vehicles have … Read more

Samsung may invest in $100M round for medical imaging startup Exo

Samsung’s venture investment unit is looking to invest in California-based medical device startup, Exo, in a round that could climb to $100 million, Bloomberg reported, citing anonymous sources. The round is being led by Sands Capital, Bold Capital and Qubit Health Capital, the report said, adding that Qubit’s chairman, Imar Ishrak, would join Exo’s board. … Read more

Nanox’s Breakthrough FDA Clearance: What It Means for Investors and the Medical Imaging Industry

As of this writing, Nanox (NASDAQ:NNOX) has seen a significant gain in today’s market, with its stock price increasing by 13.41% to $5.10 per share. This surge is largely attributed to the company’s recent FDA clearance for general use of its new imaging system, Nanox.ARC X. For those who may not be familiar, Nanox is … Read more

Biotech Breakthrough: TLX Surges 20% on Illuccix PSMA-PET Imaging Agent Approval

In a market where biotechnology stocks are often shrouded in uncertainty, Telix Pharmaceuticals (TLX) has emerged as one of the biggest gainers today. With its stock price surging by 20.51% to $23.50 per share, investors are taking notice. Telix is a clinical-stage oncology company that’s developing and commercializing therapeutic and diagnostic radiopharmaceuticals for various types … Read more

banner banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4